Form 483, Jun 3, 2025

Form 483 issued June 3, 2025 · Fort Belvoir, Virginia

Inspection
May 28 – Jun 3, 2025
Observations
3
Pages
5

In short: On June 3, 2025, FDA issued a Form 483 with 3 observations to an FDA-inspected site in Fort Belvoir, Virginia after an inspection that ran May 28 – Jun 3, 2025. The investigator was La' Tasha M. Gunter. Most observations concern biologics CGMP; the most-cited regulation is 21 CFR 606.60 (equipment).

At a glance

3 of 3 observations on this 483 concern biologics cgmp.

Biologics CGMP3

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Equipment used in the storage and distribution of blood and blood components is not observed, standardized…

  2. 02
    21 CFR 606.151

    Records including signature by the physician requesting the procedure are not maintained…

  3. 03

    Written standard operating procedures including all steps to be followed in the processing, storage and distribution…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at an FDA-inspected site?

FDA listed 3 observations on this Form 483, mostly about biologics CGMP. The most-cited regulation is 21 CFR 606.60 (equipment). The opening words of each observation are shown on this page.

Who inspected an FDA-inspected site?

La' Tasha M. Gunter is named on this Form 483, for the inspection of May 28 – Jun 3, 2025. Each investigator has a profile showing what they cite most.

When was an FDA-inspected site inspected by FDA?

The inspection ran May 28 – Jun 3, 2025, and the Form 483 is dated June 3, 2025.

How do I get the full Form 483 for an FDA-inspected site?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free